Mar 2, 2020 4:30 pm EST iBio, Inc. Announces Withdrawal of Proxy Statement Proposal to Amend Its Certificate of Incorporation to Authorize a Possible Reverse Stock Split
Dec 23, 2019 8:30 am EST iBio Announces Collaboration with EdgePoint AI for Next Gen Quality in Biologics Manufacturing
Dec 16, 2019 4:15 pm EST iBio Reports Progress on its Bio-Better Rituximab Collaboration with CC-Pharming
Dec 13, 2019 5:00 pm EST iBio, Inc. Reports on NYSE American Noncompliance Notice and Compliance Plan
Dec 10, 2019 4:44 pm EST iBio Introduces FastGlycaneering Development Service™ to Power Recombinant Protein Production